Skip to content

A randomized, single-blind, parallel prospective confirmatory clinical trial to compare and evaluate the efficacy of galvanic vestibular stimulation (GVS) on vestibular compensation and spatial cognitive function in patients with acute and chronic unilateral or bilateral vestibular dysfunction

A randomized, single-blind, parallel prospective confirmatory clinical trial to compare and evaluate the efficacy of galvanic vestibular stimulation (GVS) on vestibular compensation and spatial cognitive function in patients with acute and chronic unilateral or bilateral vestibular dysfunction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007058
Enrollment
90
Registered
2022-03-04
Start date
2022-03-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : In the unilateral (acute or chronic) or bilateral vestibular disorder patient group, the group was randomly divided into a control group and an experimental group (GVS group). The st

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Patients who meet the diagnostic criteria for acute unilateral vestibular dysfunction (Acute UVD) B. Chronic unilateral vestibular dysfunction (Chronic UVD) Patients who meet the following criteria C. Patients who meet the diagnostic criteria for bilateral vestibular dysfunction (BVD) D. Those who have a history of causing vestibular dysfunction and cognitive decline or have no history of neurodegenerative diseases such as stroke or dementia E. A person who can understand the research contents, follow instructions, and can communicate F. Those who consented to participation in the study and follow-up G. 20 years old or older and less than 70 years old

Exclusion criteria

Exclusion criteria: A. Those who show abnormal findings in neurological examination B. A person with a structural abnormality of the brain C. There are other clinically serious diseases (cerebrovascular disease, cardiopulmonary disease, liver disease, kidney disease, malignancy, musculoskeletal disease, psychiatric disease and neurodegenerative disease that can affect cognitive function) D. Those who are taking medications for epilepsy or have a history of convulsions E. Women of childbearing potential and pregnant women F. Persons with dermatological diseases, scars, or trauma at the site of application of the medical device G. Persons who have installed metal devices inside and outside the body (considering those who cannot take MRI) H. Those who do not agree to participate in the research I. Subjects who participated in similar clinical trials within the last year

Design outcomes

Primary

MeasureTime frame
Evaluating the difference in gain and corrective saccade pattern in the vestibular function test (vHIT), the result value of the spatiotemporal function cognitive function test (VOSP, Corsi block test), Morris water maze and the fMRI signal change according to whether galvanic vestibular stimulation was performed.

Secondary

MeasureTime frame
Check the following differences according to the left and right directions ; Gain and corrective saccades in the vestibular function test (vHIT), Result of spatiotemporal function cognitive function test (VOSP, Corsi block test), Morris water maze and fMRI signal change

Countries

Korea, Republic of

Contacts

Public ContactJin-Ju Kang

Jeonbuk National University Hospital

jinj_k@naver.com+82-63-250-1590

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026